These final results, along with a previous report demonstrating that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like actions in mice,2 assist the principle of targeting ACKR3 as a unique method to modulate the opioid process, which could open up new therapeutic avenues for opioid-related Diseases. At times I receive https://leopoldof406rye7.bleepblogs.com/profile